Ikarian Capital, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 217 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2022$3,232,000
-20.9%
64,0000.0%0.59%
+9.5%
Q1 2022$4,088,000
-65.0%
64,000
-46.7%
0.54%
+36.9%
Q1 2021$11,667,000
-13.3%
120,0000.0%0.39%
-33.7%
Q4 2020$13,457,000
-76.4%
120,000
-83.6%
0.59%
-86.9%
Q2 2020$56,945,000
+739.4%
730,062
+529.4%
4.53%
+788.6%
Q1 2020$6,784,000116,0000.51%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 423,012$41,129,0007.43%
Eagle Health Investments LP 133,163$12,947,0005.08%
DAFNA Capital Management LLC 207,911$20,215,0004.80%
Casdin Capital, LLC 1,550,000$150,707,0004.49%
SIB LLC 65,151$6,335,0003.72%
CADIAN CAPITAL MANAGEMENT, LP 913,702$88,839,0003.29%
Integral Health Asset Management, LLC 117,500$11,425,0003.26%
Rock Springs Capital Management LP 746,732$72,605,0001.58%
Avidity Partners Management LP 546,000$53,088,0001.47%
Zebra Capital Management LLC 12,698$1,235,0001.36%
View complete list of BLUEPRINT MEDICINES CORP shareholders